Revance Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Revance Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q2 2024.
  • Revance Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $296K, a 93.7% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $296K -$4.42M -93.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $217K -$1.86M -89.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $321K -$1.37M -81% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $235K -$26.8M -99.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $4.72M -$14.5M -75.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.07M -$11.3M -84.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.69M +$686K +68.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27M +$18.2M +205% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $19.2M +$14.5M +303% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $13.3M +$11.6M +671% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1M -$333K -25% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $8.87M +$7.72M +669% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.77M +$3.14M +191% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.73M +$235K +15.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.33M -$335K -20.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $1.15M -$1.37M -54.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.64M -$753K -31.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.49M -$1.65M -52.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.67M -$1.58M -48.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.52M -$425K -14.4% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $2.39M -$923K -27.8% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $3.15M +$2.43M +338% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $3.25M +$2.59M +393% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $2.94M +$2.11M +252% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $3.32M +$2.43M +273% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $718K +$502K +232% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $658K +$158K +31.6% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $836K +$623K +292% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $888K +$674K +315% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $216K $0 0% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $500K +$500K Dec 31, 2016 10-K 2018-03-02
Q3 2016 $213K +$207K +3450% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $214K -$160K -42.8% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $216K -$27K -11.1% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $0 -$29K -100% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $6K -$177K -96.7% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 $374K Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $243K +$88K +56.8% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $29K -$2.98M -99% Dec 31, 2014 10-K 2016-03-04
Q3 2014 $183K Sep 30, 2014 10-Q 2014-11-13
Q1 2014 $155K Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $3.01M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.